StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.54−0.50 (-5.53%)

Close on Nov 16, 2026Market cap $297.90MP/E –Yield –

Benitec Biopharma operating margin

Operating margin is operating income as a percentage of revenue.

Benitec Biopharma's operating margin for the twelve months ending Mar 31, 2024 was -307028.6%. For fiscal 2023 it was -25441.3%, against -24457.5% the year before. The highest annual figure on record is 21.2% in fiscal 2019.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2023Jun 30, 2023-25441.3%−983.8
FY2022Jun 30, 2022-24457.5%−1413.5
FY2021Jun 30, 2021-23044.1%−14925.4
FY2020Jun 30, 2020-8118.6%−8139.8
FY2019Jun 30, 201921.2%–

Quarterly operating margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q4 FY2023CQ2 2023Jun 30, 2023-65000.0%−45660.0
Q3 FY2023CQ1 2023Mar 31, 2023-8038.9%+184711.1
Q2 FY2023CQ4 2022Dec 31, 2022-40071.4%+339228.6
Q3 FY2022CQ1 2022Mar 31, 2022-7208.3%+318691.7
Q2 FY2022CQ4 2021Dec 31, 2021-19340.0%−14449.1
Q4 FY2021CQ2 2021Jun 30, 2021-192750.0%−185210.7
Q3 FY2021CQ1 2021Mar 31, 2021-379300.0%−376558.4
Q2 FY2021CQ4 2020Dec 31, 2020-325900.0%−322366.7
Q1 FY2021CQ3 2020Sep 30, 2020-4890.9%–
Q3 FY2020CQ1 2020Mar 31, 2020-7539.3%–
Q2 FY2020CQ4 2019Dec 31, 2019-2741.6%–
Q1 FY2020CQ3 2019Sep 30, 2019-3533.3%–

More Benitec Biopharma figures

See a number that looks wrong?